FAQ

Ismigen

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2015
0120032015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD…
Polyvalent mechanical bacterial lysates (PMBLs) have been shown to reduce the number of infectious episodes in patients with… (More)
Is this relevant?
2009
2009
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone.
BACKGROUND This study investigated the value of adding Ismigen, a polyvalent mechanical bacterial lysate, to therapy of COPD… (More)
Is this relevant?
2005
2005
Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections.
One hundred and fourteen patients with a medical history of recurrent upper respiratory tract infections (at least four episodes… (More)
Is this relevant?
2004
2004
Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
UNLABELLED The aim of the present study was to evaluate the efficacy of the immunostimulating therapy with a new vaccine Ismigen… (More)
Is this relevant?
2003
2003
Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels.
Lyophilized bacterial lysates, which actively stimulate the immune response, are widely used as vaccines or 'biological response… (More)
Is this relevant?